Morgans healthcare analyst Scott Power said ASX health stocks have risen in past five days despite higher than expected inflation ...
Vous n'êtes pas connecté
Immutep sinks 35pc despite revealing positive topline results for cancer-treatment trial. Investors may have had higher expectations. ...
Morgans healthcare analyst Scott Power said ASX health stocks have risen in past five days despite higher than expected inflation ...
Positive feedback from the FDA has given Cleo Diagnostics confidence in its US regulatory strategy. Race Oncology confirms RC220's safety. ...
Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal cancer, also known as...
A higher-than-expected inflation rate of 4 per cent for May has raised expectations the Reserve Bank will have to raise rates at its next meeting.
Morgans analyst Scott Power said ASX health stocks have fallen for the first week of the 2025 financial year as ...
Island Pharmaceuticals (ASX:ILA) inks deal with Nasdaq-listed BioCryst Pharmaceuticals for potential Ebola treatment. ...
Universal Health Services (UHS) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for...
US stocks have closed higher as investors digested comments from Federal Reserve chair Jerome Powell.
Health Minister Hon. Sir Molwyn Joseph is hopeful the new investors will reopen the Cancer Centre in St John’s within 45 days. Minister Joseph has...